USSTOCK.TODAY
Market Closed Log in Sign up

GSK reports 8.9 billion pounds in Q3 revenue with 15% growth in specialty segment

The Motley Fool +1 · ·by G4L

GSK GSK Plc ADR
$47.76 -0.13%
View chart & analysis →
  1. 1GSK recorded 8.9 billion pounds in Q3 revenue.
  2. 2The GSK specialty segment saw 15% growth during the quarter.
  3. 3GSK has conducted 18 Phase 3 clinical trials to date.

So what's the key point?

GSK's Q3 revenue was 8.9 billion pounds. The specialty segment grew by 15%, and 18 Phase 3 clinical trials were conducted.

Source The Motley Fool +1 · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →